Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huntington Potter

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Geriatric Psychiatry|July 1, 2009
Diagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDRRanjan Duara, David A Loewenstein, Maria T Greig-Custo, et al.
Frontiers in Cellular Neuroscience|February 7, 2024
Human iPSC-derived retinal organoids develop robust Alzheimer's disease neuropathologyEthan James, Anne Vielle, Karen Cusato, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 23, 2010
Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studiesRanjan Duara, David A Loewenstein, Maria Greig, et al.
Neurobiology of Aging|May 30, 2006
Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanismsDavid A Costa, Jennifer R Cracchiolo, Adam D Bachstetter, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 23, 2011
Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression ratesRanjan Duara, David A Loewenstein, Maria T Greig, et al.
Journal of Neurovirology|May 10, 2020
Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenicAndrew N Bubak, Cheryl Beseler, Christina N Como, et al.
Alzheimer'S Research & Therapy|June 29, 2022
Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer's disease cognitionNoah R Johnson, Athena C-J Wang, Christina Coughlan, et al.
Journal of Alzheimer'S Disease : JAD|July 8, 2009
Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease miceGary W Arendash, Takashi Mori, Chuanhai Cao, et al.
Dementia and Geriatric Cognitive Disorders|April 16, 2011
Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairmentDaniel Varon, David A Loewenstein, Elizabeth Potter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's diseaseQian Shen, David A Loewenstein, Elizabeth Potter, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Geriatric Psychiatry|July 1, 2009
Diagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDRRanjan Duara, David A Loewenstein, Maria T Greig-Custo, et al.
Frontiers in Cellular Neuroscience|February 7, 2024
Human iPSC-derived retinal organoids develop robust Alzheimer's disease neuropathologyEthan James, Anne Vielle, Karen Cusato, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 23, 2010
Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studiesRanjan Duara, David A Loewenstein, Maria Greig, et al.
Neurobiology of Aging|May 30, 2006
Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanismsDavid A Costa, Jennifer R Cracchiolo, Adam D Bachstetter, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 23, 2011
Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression ratesRanjan Duara, David A Loewenstein, Maria T Greig, et al.
Journal of Neurovirology|May 10, 2020
Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenicAndrew N Bubak, Cheryl Beseler, Christina N Como, et al.
Alzheimer'S Research & Therapy|June 29, 2022
Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer's disease cognitionNoah R Johnson, Athena C-J Wang, Christina Coughlan, et al.
Journal of Alzheimer'S Disease : JAD|July 8, 2009
Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease miceGary W Arendash, Takashi Mori, Chuanhai Cao, et al.
Dementia and Geriatric Cognitive Disorders|April 16, 2011
Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairmentDaniel Varon, David A Loewenstein, Elizabeth Potter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's diseaseQian Shen, David A Loewenstein, Elizabeth Potter, et al.
Pageof 10